Repositioned Nefiracetam: Myelin Repair in Multiple Sclerosis. Licensing opportunity from University College Dublin - August 2015 front page preview

Repositioned Nefiracetam: Myelin Repair in Multiple Sclerosis. Licensing opportunity from University College Dublin - August 2015

Nefiracetam is repositioned as a treatment to promote remyelination in MS. The success of immunomodulator drugs in MS has shifted the discovery focus to remyelination and neuroprotection. The outstanding relief unmet nee...

pdf 369.5KB